Mary Mosher

Array ( [id] => 6000742 [patent_doc_number] => 20110117118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'MOLECULES, COMPOSITIONS, METHODS AND KITS FOR APPLICATIONS ASSOCIATED WITH FLAVIVIRUSES' [patent_app_type] => utility [patent_app_number] => 13/014566 [patent_app_country] => US [patent_app_date] => 2011-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18843 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117118.pdf [firstpage_image] =>[orig_patent_app_number] => 13014566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212383 [patent_doc_number] => 20110135683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'MODIFIED VACCINIA VIRUS ANKARA FOR THE VACCNATION OF NEONATES' [patent_app_type] => utility [patent_app_number] => 13/009636 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13366 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135683.pdf [firstpage_image] =>[orig_patent_app_number] => 13009636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174052 [patent_doc_number] => 20110177028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'INTERFERON-BETA AND/OR LAMBDA FOR USE IN TREATING RHINOVIRUS INFECTION IN THE ELDERLY' [patent_app_type] => utility [patent_app_number] => 13/007541 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5567 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177028.pdf [firstpage_image] =>[orig_patent_app_number] => 13007541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6165843 [patent_doc_number] => 20110195506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'METHOD FOR PRODUCING YEAST EXPRESSED HPV TYPES 6 AND 16 CAPSID PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/005265 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9563 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195506.pdf [firstpage_image] =>[orig_patent_app_number] => 13005265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7656844 [patent_doc_number] => 20110306113 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Scalable Process for Protein Purification' [patent_app_type] => utility [patent_app_number] => 12/978333 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18153 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306113.pdf [firstpage_image] =>[orig_patent_app_number] => 12978333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476592 [patent_doc_number] => 20120275999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'ONCOLYTIC RHABDOVIRUS' [patent_app_type] => utility [patent_app_number] => 13/514837 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 32418 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691307 [patent_doc_number] => 08821897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Viral adjuvants' [patent_app_type] => utility [patent_app_number] => 12/954021 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 25772 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12954021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10897603 [patent_doc_number] => 08920812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS' [patent_app_type] => utility [patent_app_number] => 13/505250 [patent_app_country] => US [patent_app_date] => 2010-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 32713 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8548778 [patent_doc_number] => 08323658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Infectious bursal disease virus antigenic isolates and vaccines' [patent_app_type] => utility [patent_app_number] => 12/914591 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6860 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12914591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9085830 [patent_doc_number] => 08557253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-15 [patent_title] => 'Stabilizing excipient for inactivated whole virus vaccine' [patent_app_type] => utility [patent_app_number] => 12/899492 [patent_app_country] => US [patent_app_date] => 2010-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13024 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12899492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8720204 [patent_doc_number] => 20130071421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'TURKEY VIRAL HEPATITIS VIRUS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/499871 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 27263 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148684 [patent_doc_number] => 20110020279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'RABIES CURE' [patent_app_type] => utility [patent_app_number] => 12/893827 [patent_app_country] => US [patent_app_date] => 2010-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 34732 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020279.pdf [firstpage_image] =>[orig_patent_app_number] => 12893827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417021 [patent_doc_number] => 20120244521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'Methods for identifying a virulent strain of a virus' [patent_app_type] => utility [patent_app_number] => 13/261189 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 10100 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054620 [patent_doc_number] => 20110110980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'HETERLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN' [patent_app_type] => utility [patent_app_number] => 12/869832 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8051 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110980.pdf [firstpage_image] =>[orig_patent_app_number] => 12869832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024170 [patent_doc_number] => 20110052496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'HOLLOW NANOPARTICLES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/870215 [patent_app_country] => US [patent_app_date] => 2010-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26817 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052496.pdf [firstpage_image] =>[orig_patent_app_number] => 12870215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8920487 [patent_doc_number] => 08486418 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Recombinant avian paramyxovirus vaccine and method for making and using thereof' [patent_app_type] => utility [patent_app_number] => 12/860589 [patent_app_country] => US [patent_app_date] => 2010-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 21067 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 346 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12860589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968437 [patent_doc_number] => 08507247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Influenza A virus with attenuating mutations in NS2 protein' [patent_app_type] => utility [patent_app_number] => 12/854578 [patent_app_country] => US [patent_app_date] => 2010-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14787 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12854578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5992986 [patent_doc_number] => 20110014639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'HYBRIDOMA CELL LINE PRODUCING MONOCLONAL ANTIBODY AGAINST FOOT-AND-MOUTH DISEASE VIRUS, THE MONOCLONAL ANTIBODY THEREFROM, IMMUNOASSAY REAGENT AND KIT, AND IMMUNOASSAY METHOD' [patent_app_type] => utility [patent_app_number] => 12/835412 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7957 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20110014639.pdf [firstpage_image] =>[orig_patent_app_number] => 12835412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703345 [patent_doc_number] => 08828407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Chimaeric protein' [patent_app_type] => utility [patent_app_number] => 13/382119 [patent_app_country] => US [patent_app_date] => 2010-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 8822 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776425 [patent_doc_number] => 20120039935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'METHODS OF TREATING MEASLES INFECTIOUS DISEASE IN MAMMALS' [patent_app_type] => utility [patent_app_number] => 12/817125 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 32614 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039935.pdf [firstpage_image] =>[orig_patent_app_number] => 12817125 [rel_patent_id] =>[rel_patent_doc_number] =>)